Patrick Ming Kuen TANG (邓铭权)B.Sc., Ph.D. (CUHK)patrick.tang@cuhk.edu.hk Dr. Patrick Tang completed his Bachelor of Science and Doctoral of Philosophy degrees in the Department of Biochemistry, The Chinese University of Hong Kong. He was a recipient of China Exchange Fellowship from Cancer Research UK and continued his postdoctoral training at University of Oxford. Then, he was appointed as a research manager responsible for business development and translational research of human mesenchymal stem cells in Hong Kong. Afterward, he rejoined CUHK and worked in Li Ka Shing Institute of Health Sciences and Department of Anatomical and Cellular Pathology since 2014, then got promoted to be research assistant professor in 2017.

Patrick is currently an assistant professor in the department since 2020. He would dissect the pathogenic roles and molecular mechanisms of innate immunity for promoting renal disease and cancer by bioinformatics approaches at single-cell resolution. He has received young investigator awards in ISN Frontiers Meeting 2018 (Tokyo) and East Meets West Symposium 2018 (Hong Kong), Faculty Innovation Award 2019 (CUHK Medicine), 7th Youth Dream Makers 2021 (Hong Kong) and Gold Medal with Congratulations of the Jury Medal in Inventions Geneva 2021 (Switzerland). He has published more than 60 research papers with more than 2000 citations on high impact research journals including Nature Reviews Nephrology, Nature Communications, Proceedings of the National Academy of Sciences, Molecular Cancer, Advanced Science, Cancer Immunology Research, Kidney International, Diabetes, Molecular Therapy, etc. Dr. Tang wishes can incubate new generation to translate his bench-top discovery from the inflammatory microenvironments into novel therapy for human diseases.
Research Interests:
Identification of Pathogenic and Anticancer factors from the Tumor Microenvironment
Development of Novel Immunotherapy for Cancer and Kidney Diseases
Improvement of Gene Therapy
Research Grants
General Research Fund (2019, 2020, 2021) -Regulatory Role and Mechanism of Immunosuppression of Neutrophil Anticancer Activities (HKD 1,151,040)
-Functional Role and Regulatory Mechanism of MNT Transition in Tumor Microenvironment (HKD 1,074,019)
-Elucidating the Pathogenic Role and Regulatory Mechanism of TAM-CAF Transition in NSCLC at Single-Cell Resolution (HKD 996,285)

Innovation and Technology Fund ITSP Tier 3 (2019, Co-I in 2016 and 2018)
-Development of a Novel Virus-free Anticancer Gene Therapy: USMB-shMincle (HKD 1,391,500)
Faculty Innovation Award, Scheme A, CUHK Medicine 2019 (HKD 2,500,000)
Health and Medical research Fund (Co-I in 2016, 2017, 2018, and 2019)
Direct Grant for Research CUHK (2018, 2019, 2020)

Awards
2021: Gold Medal with Congratulations of the Jury Medal in Inventions Geneva 2021 (Switzerland)
2021: 7th Youth Dream Makers 2021 (Hong Kong)
2019: Faculty Innovation Award (Scheme A), Faculty of Medicine, CUHK
2018: Frontiers Young Investigator Award, Winner, International Society of Nephrology (Tokyo)
2018: Young Investigator Award, First Runner-up, East Meets West Symposium, Hong Kong
2018: Poster Award, Hong Kong Immunology Forum
2018: Poster Award, SYSU-CUHK State Key Laboratory Retreat Conference
2009: Postdoctoral Research Fellowship (Oxford-China Exchange), Cancer Research UK
2006: Postgraduate Students Publication Award, Department of Biochemistry, CUHK

Press Releases
CUHK Students Win Awards in the 7th Hong Kong University Student Innovation and Entrepreneurship Competition (July 2021)
https://www.cpr.cuhk.edu.hk/en/press/cuhk-students-win-awards-in-the-7th-hong-kong-university-student-innovation-and-entrepreneurship-competition/
https://www.wenweipo.com/a/202107/06/AP60e4161de4b08d3407cbb907.html

Gold Medal with Congratulations of the Jury: A Novel Virus-Free Anticancer Gene Therapy (March 2021)
https://www.med.cuhk.edu.hk/research/feature-story-1
https://www.facebook.com/urbanlifehk.health/videos/147574050623179/

CUHK Uncovers How Immune Cells Turn Bad A New Hope for Kidney Patients (October 2020)
https://www.med.cuhk.edu.hk/press-releases/cuhk-uncovers-how-immune-cells-turn-bad-a-new-hope-for-kidney-patients
https://orientaldaily.on.cc/cnt/news/20201009/00176_060.html

CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy (April 2017)
https://www.med.cuhk.edu.hk/press-releases/cuhk-uncovers-novel-immune-escape-mechanism-of-cancer-opening-up-new-direction-for-cancer-immunotherapy
https://www.thestandard.com.hk/section-news/section/4/181655/Uni's-cancer-discovery-sparks-hopes-of-new-therapy

Journal Editorship
2018-present: Journal of Cellular and Molecular Medicine
2018-2020: Chung Chi College Staff Club Executive Committee
2018-present: Committee member of Hong Kong Society of Flow Cytometry
2018-present: Frontiers in Physiology [Research Topic: Immune Landscape of Kidney Pathology]
2021-present: Frontiers in Oncology [Research Topic: New Insights into Fibrotic Signaling in Cancer]


Patent
- Virus-free Gene Transfer Method for Tissue-Specific Targeting MINCLE (US Provisional 62/987,079)
- Naringenin and Asiatic Acid Combination Treatment of Diabetes (US Provisional 62/960,512)
- Neutrophil-Based Composition and Use thereof filed by Hong Kong


Research opportunity:
Postgraduate study and internship are welcome.


Selected Publications (ORCID: 0000-0002-3194-3736)Smad3 Promotes Cancer-Associated Fibroblasts Generation via Macrophage-Myofibroblast Transition. PC Tang, JY Chung, VW Xue, J Xiao, XM Meng, XR Huang, S Zhou, AS Cheng, TL Lee, KT Leung, EW Lam, KF To, PM Tang (co-correspondence), HY Lan. Advanced Science 2021 (Impact factor: 16.8). In Press.

USMB-shMincle: a virus-free gene therapy for blocking M1/M2 polarization of tumor-associated macrophages. VW Xue , JY Chung , PC Tang, AS Chan, TW To, JS Chung, F Mussal, EW Lam, C Li, KF To, KT Leung, HY Lan, PM Tang. Molecular Therapy Oncolytics. 2021 Aug 25;23:26-37. (IF: 7.20)

DPP4/CD32b/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy. Tang PM (co-correspondence), Zhang YY, Hung JS, Chung JY, Huang XR, To KF, Lan HY. Molecular Therapy. 2021 Jan 6;29(1):365-375. (IF: 11.454)

Neural transcription factor Pou4f1 promotes renal fibrosis via macrophage-myofibroblast transition. Tang PM (co-correspondence), Zhang YY, Xiao J, Tang PC, Chung JY, Li J, Xue VW, Huang XR, Chong CC, Ng CF, Lee TL, To KF, Nikolic-Paterson DJ, Lan HY. PNAS 2020 Aug 25;117(34):20741-20752. (IF: 11.21)

The Mincle/Syk/NF-κB Signalling Circuit is Essential for Maintaining the Protumoral Activities of Tumor-associated Macrophages. Li C, Xue VW, Wang QM, Lian GY, Huang XR, Lee TL, To KF, Tang PM (co-correspondence), Lan HY. Cancer Immunol Res. 2020 Aug;8(8):1004-1017. (IF: 11.15)

Macrophages: versatile players in renal inflammation and fibrosis. Tang PM, Nikolic-Paterson DJ, Lan HY. Nat Rev Nephrol 2019 ;15(3):144-158. (IF: 28.31)

Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development. Tang PM, Zhou S, Meng XM, Wang MQ, Li CJ, Lian GY, Huang XR, Tang YJ, Guan XY, Yan BP, To KF, Lan HY. Nature Communications, 8, 14677, 2017. (IF: 14.92)

LRNA9884, a Novel Smad3-Dependent LncRNA, Promotes Diabetic Kidney Injury in db/db Mice Via Enhancing MCP-1-Dependent Renal Inflammation. Zhang YY*, Tang PM*(co-first), Tang PC, Xiao J, Huang XR, Yu C, Ma RCW, Lan HY. Diabetes. 68:1485-1498, 2019 [Cover Image of Diabetes July 2019]. (IF: 9.46)

The proto-oncogene tyrosine protein kinase Src is essential for macrophage-myofibroblast transition during renal scarring. Tang PM, Zhou S, Li CJ, Liao J, Xiao J, Wang QM, Lian GY, Li J, Huang XR, To KF, Ng CF, Chong CC, Ma RC, Lee TL, Lan HY. Kidney Int. 93:173-187, 2018. (IF: 10.61)

Enhanced cancer immunotherapy with Smad3-slilencing NK-92 cells. Wang QM*, Tang PM*(co-first), Lian GY, Li C, Li J, Huang XR, To KF, Lan HY. Cancer Immunol Res. 2018 Aug;6(8):965-977. (IF: 11.15)

Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in db/db Mice by Targeting miR-29b. Sun SF*, Tang PMK*(co-first), Feng M, Xiao J, Huang XR, Li P, Ma RCW, Lan HY. Diabetes. 67:731-744, 2018. [Highlighted by Editorial Commentary]. (IF: 9.46)

TGF-β Mediates Renal Fibrosis via the Smad3-Erbb4-IR Long Noncoding RNA Axis. Feng M*, Tang PM*(co-first), Huang XR, Sun SF, You YK, Xiao J, Lv LL, Xu AP, Lan HY. Mol Ther. 2018 Jan 3;26(1):148-161. (IF: 11.454)

Photodynamic Therapy Inhibits P-glycoprotein Mediated Multidrug Resistance via JNK Activation in Human Hepatomacellular Carcinoma Using the Photosensitizer Pheophorbide a. Tang PM, Zhang DM, Bui Xuan NH, Tsui SK, Waye MM, Kong SK, Fong WP, Fung KP. Molecular Cancer 2009; 8:56. (IF 27.401)

Pheophorbide a based photodynamic therapy induces apoptosis via mitochondrial-mediated pathway in human uterine carcinosarcoma. Tang PM, Liu XZ, Zhang DM, Fong WP, Fung KP. Cancer Biol Ther 2009 Mar 15;8(6):533-9. [Highlighted by Editorial Commentary]. (IF: 4.74)

Pheophorbide a, An Active Compound Isolated from Scutellaria barbata, Possesses Photodynamic Activities by Inducing Apoptosis in Human Hepatocellular Carcinoma. Tang PM, Chan JY, Au SW, Kong SK, Tsui SK, Waye MM, Mak TC, Fong WP, Fung KP. Cancer Biol Ther. 2006; 5: 1111-1116. (IF: 4.74)